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Abstract
Despite the increased understanding of colorectal cancer and the introduction of targeted
drug therapy, the metastatic phase of the disease remains refractory to treatment. Since the
deregulation of normal apoptosis contributes to the pathogenesis of colorectal cancer,
novel nucleoside analogues were synthesized here and evaluated for their ability to induce
apoptosis and cause cell death in two colorectal adeno-carcinoma cell lines, Caco-2 and
HT-29. Three novel nucleoside analogues assessed here showed cytotoxic activity, as
measured by the MTT assay against both cell lines: the IC50 values ranged between 3 and
37 μM, with Caco-2 cells being more sensitive than HT-29 cells. Compared to camptothe-
cin, the positive control, the nucleoside analogues were significantly less toxic to normal
unstimulated leukocytes (p>0.05). Moreover, the nucleosides were able to induce apoptosis
as measured by an increase in caspase 8 and caspase 3 activity above that of the control.
This was additionally supported by data derived from Annexin V-FITC assays. Despite mar-
ginal changes to the mitochondrial membrane potential, all three nucleosides caused a sig-
nificant increase in cytosolic cytochrome c (p>0.05), with a corresponding decrease in
mitochondrial cytochrome c. Morphological analysis of both cell lines showed the rapid
appearance of vacuoles following exposure to two of the nucleosides, while a third caused
cellular detachment, delayed cytoplasmic vacuolisation and nuclear abnormalities. Prelimi-
nary investigations, using the autophagic indicator monodansylcadaverine and chloroquine
as positive control, showed that two of the nucleosides induced the formation of autophagic
vacuoles. In summary, the novel nucleoside analogues showed selective cytotoxicity
towards both cancer cell lines and are effective initiators of an unusual apoptotic response,
demonstrating their potential to serve as structural scaffolds for more potent analogues.
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Introduction
There has been substantial progress in the understanding of the molecular mechanisms under-
lying colorectal cancer. However, despite the use of targeted drug therapy, colorectal cancer
remains associated with a poor prognosis. While drugs like bevacizumab have improved the
survival period for metastatic disease beyond 20 months, they have not been able to affect a
cure. Recently, clinical trials have demonstrated the failure of tyrosine kinase inhibitors such as
sunitinib, which caused an increase in severity and incidence of serious adverse drug reactions
with minimal therapeutic benefit [1]. Therefore, the search for effective agents to treat
advanced colorectal cancer remains a priority.
Numerous studies have shown that the normal apoptotic process is dysfunctional in colo-
rectal cancer [2–5]. Dysregulation of apoptosis contributes to the development of resistance to
chemotherapy and a poor prognosis [6]. Apoptosis, as first described by Kerr in 1972 [7], is
characterised by a number of morphological changes, including plasma membrane blebbing,
chromatin condensation, nuclear fragmentation and formation of apoptotic bodies. Hallmarks
of apoptosis include the exposure of phosphatidylserine on the outer leaflet of the plasma
membrane [8, 9], changes to mitochondrial membrane permeability [10] and the release of
cytochrome c from the mitochondrial inter-membrane space, with the subsequent activation
of effector caspases [11].
Apoptosis is essential for the regulation of normal cell turnover of the intestinal epithelium.
However, in colorectal cancer, both the extrinsic and the intrinsic apoptotic pathways are com-
promised favouring the proliferation of neoplastic cells. In colorectal cancer, despite FAS
receptor expression, cells are resistant to FAS ligand mediated apoptosis indicating a defect in
FAS mediated signalling [12]. TNF related apoptosis inducing ligand (TRAIL) receptor medi-
ated apoptosis is normally upregulated in cancer cells; however, in colorectal cancer, resistance
to TRAIL receptor mediated apoptosis has been observed [13]. The p53 tumour suppressor
gene product is mutated or absent in 85% of colorectal cancers. This transcription factor is
essential for the activation of the intrinsic apoptotic pathway as well as the expression of the
cyclin dependent kinase inhibitor p21waf1/Cip1. Cells that are defective in p53 have decreased
levels of apoptotic proteins, thereby favouring the proliferation of neoplastic cells [14].
Chemotherapeutic agents that are able to induce apoptosis are beneficial, since they bring
about death of cancer cells without triggering the inflammatory response and the tumour lysis
syndrome associated with necrosis. Nucleoside analogues are used extensively to treat cancer
and manage viral infections like Herpes and HIV. Drugs belonging to this class are known to
induce apoptosis in the cancers where they are effective [15].
In the present study, novel nucleoside analogues were screened against two colon cancer cell
lines, to investigate both their cytotoxic effects and their potential to induce apoptosis. We
showed that despite showing relatively high IC50 values as determined by the MTT cytotoxicity
assay, some nucleoside analogues were comparable to camptothecin with regards to their abil-
ity to induce apoptosis. Furthermore the compounds induced an unusual mitochondrial
response which may provide further clues to the underlying apoptotic abnormalities in colorec-
tal cancer.
Materials and Methods
Cell culture
HT-29 (HTB-38™) and Caco-2 (HTB-37™) human colorectal cancer cell lines obtained from
ATCC, were cultured in low glucose Dulbecco’s Modified Eagle’s Medium (DMEM) which
contained 5% heat-inactivated foetal calf serum. Culture medium and foetal calf serum were
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obtained from Highveld Biologicals, South Africa. Cells were grown in 75 cm2 culture flasks
and incubated at 37°C in a humidified atmosphere with 5% CO2. Both cell lines were subcul-
tured when they reached confluence. Briefly, cells were washed twice with 10 ml phosphate
buffered saline followed by the addition of 4 ml trypsin and incubation at 37°C for 10 minutes.
Detached cells were reseeded to the same flask. Camptothecin (Sigma), a known inducer of
apoptosis, and an inhibitor of topoisomerase-1, was used as a positive control in all experimen-
tal procedures.
Assessment of cell viability
Assessment of test nucleoside cytotoxicity was carried out by the 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide, (MTT), assay (Sigma). The Trypan Blue (Sigma) exclusion
assay was used to assess the viability of the cancer cells prior to plating cells for nucleoside cell
viability assays. Cells were seeded in 96 well plates at a cell density of 9 000 cells/well, allowed
to adhere to the growth surface for 4 hours and then exposed to the test nucleosides for 48
hours at concentrations ranging between 1 and 120 μM. The MTT assay was essentially per-
formed as described by Mossman [16] with the exception of dissolving the formazan crystals in
DMSO. Briefly, following incubation with the MTT, 100 μl of media was replaced with DMSO
to facilitate the solubilisation of the formazan crystals. The absorbance of the solubilised forma-
zan crystals was measured at 540 and 690 nm with a Labsystems iEMS plate reader. Data was
obtained from experiments that were repeated at least three times, with each data point being
determined in quadruplicate. Sigmoidal dose response curves were constructed with GraphPad
Prism, version 5.
Isolation of human peripheral leukocytes
Permission to isolate human leukocytes from healthy volunteers was obtained from the
Human Ethics Committee of the Faculty of Health Sciences, University of the Witwatersrand
(clearance number, M070519). Written, informed consent from each donor was obtained for
the experimental use of her/his leukocytes in research. Peripheral leukocytes from a single
donor were isolated from blood collected in a heparinised tube. Red blood cells were selectively
lysed by using the Versagene Blood DNA Kit (Gentra Systems). Freshly prepared leukocytes
were used to determine nucleoside toxicity to normal cells. The leukocytes were transferred to
RPMI (Highveld Biologicals) culture medium supplemented with 2 mM glutamine (Sigma)
and 10% foetal calf serum (Separations). Following the harvesting of the leukocytes, their via-
bility was determined by the Trypan Blue exclusion assay before they were exposed to the test
nucleosides for 24 hours.
Assessment of apoptosis
Induction of caspase 3 and caspase 8 activity. Caspase 3 and caspase 8 specific colorimet-
ric assays, namely CPP32 and FLICE, were used to measure caspase activity as per the manu-
facturer’s protocol (Biovision Research Products). The level of caspase activity in the cell
lysates was directly proportional to the absorbance of p-nitroaniline (pNA) measured at 405
nm in a Labsystems iEMS Multiscan plate reader. Cells were seeded in 6 well plates at a density
of 50 000 cells per well and allowed grow for 18 hours before treatment with nucleosides. The
protein content was standardised in all test samples. Caspase 3 and caspase 8 activity was mea-
sured following different exposure periods of the cells to the test nucleosides, typically at 2, 4, 8,
12, and 24 hours after the addition of the nucleosides to the cultured cells.
Measurement of the mitochondrial membrane potential. The cationic dye 5,5’,6,6’-tet-
rachloro-1,1’,3,3’-tetraethylbenzimidazolcarbocyanine iodide (JC-1) is selective for
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mitochondria and its inherent fluorescence makes it useful to measure the electrochemical gra-
dient that exists across the mitochondrial membrane. The protocol was followed as per the
manufacturer’s specifications (BD Pharmingen). The JC-1 dye accumulates in the mitochon-
dria of healthy cells as fluorescent red aggregates. Cells were seeded in 6 well plates at a density
of 50 000 cells per well and allowed grow to near confluency before treatment with nucleosides.
Flow cytometry, with excitation/emission filters of 485/540 nm (green fluorescence) and 540/
590 nm (red fluorescence), was used to measure the effect of the test nucleosides on mitochon-
drial membrane potential. The mitochondria containing red JC-1 aggregates in healthy cells
were detected in the FL-2 channel (upper gate in the scattergraphs), whereas green JC-1 mono-
mers in apoptotic cells were detected in the FL-1 channel (lower gate in the scattergraphs).
Measurement of mitochondrial and cytoplasmic cytochrome c. The human cytochrome
c Titerzyme Enzyme Immunometric Assay (Assay Designs Inc.) was used to measure the con-
centration of cytochrome c in the mitochondrial and the cytoplasmic fractions of cells exposed
to the test nucleosides. Cells were seeded in 6 well plates at a density of 50 000 cells per well
and allowed grow for 18 hours before treatment with nucleosides. The treated cells were har-
vested and rinsed with ice-cold phosphate buffered saline. The cytosolic fraction was obtained
by resuspending the cell pellet with a cell permeabilization buffer, (250 mM sucrose, 137 mM
NaCl, 70 mM KCl, 4.3 mM Na2HPO4, 1.4 mM K2HPO4, 0.2 mg/ml Digitonin and 0.1%
Hydorol M) supplied in the Mitochondrial isolation kit, (Assay Designs Inc.) which left the
mitochondria intact. This was followed by centrifugation to separate the cytosolic fraction and
to pellet the mitochondria. The mitochondria were then lysed with RIPA buffer, consisting of
50 mM Tris-HCl, pH 7.4, 150 mMNaCl, 1mM EDTA, 1mM EGTA, 1% Triton X-100, 1%
sodium deoxycholate and 0.1% SDS.
Determination of apoptosis as measured by the annexin V assay. Phosphatidylserine
(PS) translocation to the outer cell membrane was determined by fluorescein isothiocyanate
(FITC)-labelled Annexin V. Flow cytometric analyses with FITC-labelled annexin V and pro-
pidium iodide were performed according to the manufacturer’s protocol (BD Pharmingen), on
cells exposed to 100 μM of each of the test nucleosides or camptothecin for 24 hours. Cells
were seeded in 6 well plates at a density of 50 000 cells per well and allowed to grow to near
confluency before treatment with nucleosides. Cell staining was assessed using Annexin
V-FITC (green fluorescence) as well as a dye exclusion of propidium iodide (PI) (negative for
red fluorescence), recording at least 104 events. Following exposure to the test nucleosides, the
cells were harvested and analysed by flow cytometry on a BD LSR II flow cytometer. The data
was plotted as a scattergraph with FITC-Annexin V (green fluorescence) represented on the X-
axis versus PI (red fluorescence) on the Y-axis.
Caspase 9 activity. Caspase 9 activity was determined with the Abcam1 Caspase 9 active
FITC staining kit. The caspase 9 selective inhibitor LEHD-FMK conjugated to FITC penetrates
live cells to bind to active caspase 9 in an irreversible manner. Cells were seeded on sterile cov-
erslips (50 000 per coverslip) allowed to adhere for four hours and exposed to the test nucleo-
sides and camptothecin, respectively, for 24 hrs. Thereafter cells were washed with PBS and
then incubated with the substrate at 37°C for one hour. Slides were washed in PBS and viewed
on an Olympus BX41 epifluorescence microscope. Images were captured with an Olympus
DP72 camera and analysed with the Olympus CellSens Software package. Cells with activated
Caspase 9 display a bright green fluorescence.
Assessment of HT-29 and Caco-2 cell morphology
The effect of the nucleosides on cell morphology was assessed by phase contrast and fluores-
cence microscopy. For phase contrast microscopy, cells were grown in 6 well culture plates
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(50 000 cells per well), allowed to adhere overnight and then exposed to nucleosides for various
time periods. All experiments were repeated at least three times. Cells were observed with an
Olympus CKX41 inverted microscope and images were captured with an Olympus DP21 cam-
era. Cell morphology was further evaluated with the Hoechst 33342 (Life Technologies) and
acridine orange (Life Technologies) fluorescent dyes. Cells were cultured on heat sterilised
glass coverslips and exposed to the test nucleosides at varying concentrations. Using the appro-
priate filters, cells were observed with an Olympus BX41 epifluorescence microscope. Images
were captured with an Olympus DP72 camera and analysed with the Olympus CellSens Soft-
ware package.
Assessment of Bcl-2 and Bax expression
The expression and cellular location of both Bcl-2 and Bax in the HT-29 and Caco-cell lines
were determined by immunofluorescence microscopy. Cells were grown on coverslips (50 000
cells per coverslip), allowed to adhere overnight and exposed to the test nucleosides and camp-
tothecin for 6 hours. After rinsing with PBS, cells were fixed with 3% formaldehyde in PBS for
20 minutes. The cells were rinsed and permeabilized for 5 minutes with 0.25% Triton X100,
prepared in PBS with 0.5% bovine serum albumin (BSA). Following permeabilization, cells
were blocked with 1% (BSA) in PBS for 1 hour. Thereafter cells were washed and incubated
overnight with the respective primary antibodies (Bcl-2 or Bax in PBS with 0.5% BSA) at 4°C.
Mouse anti-Bcl-2 and mouse anti-Bax was obtained from Biovision and used at a concentra-
tion of 10 mg/mL. After washing with PBS, cells were incubated with species compatible
Alexa-fluor 568 (Abcam) secondary antibody. FITC-conjugated phalloidin, (Abcam), was used
to visualize the cytoskeleton and the nuclei were visualized with Hoechst 33342 stain as
described previously. The cells were viewed using an Olympus BX41 epifluorescence micro-
scope with the appropriate filters for each fluorochrome. Images were captured with an Olym-
pus DP72 camera and analysed with the Olympus CellSens Software package.
Evaluation of cells for induction of autophagy
Cells were grown on sterile coverslips in 6 well plates 9 (50 000 cells per coverslip) allowed to
adhere overnight and treated with 50 μM of test nucleosides. Chloroquine (50 μM) was used as
a positive control since it is known to cause extensive autophagic vacuole formation [17, 18].
Cells were exposed to test compounds, chloroquine and camptothecin for 3 hours, washed
with PBS and then incubated at 37°C with 50 μMmonodansyl-cadaverine (MDC) (Sigma), in
PBS for 15 minutes [19, 20, 21]. Camptothecin was included as a negative control for vacuole
formation as it failed to cause vacuole formation in the two cell lines. Coverslips were rinsed
with PBS and the live cells were viewed under the Olympus BX41 epifluorescence microscope.
Images were captured with an Olympus DP72 camera and analysed with the Olympus CellSens
Software package.
Nucleoside test compounds
The novel nucleoside derivatives, nucleoside 1, 2 and 5 evaluated in this study were synthesised
in the School of Chemistry, University of the Witwatersrand, and characterized by 1H and 13C
NMR, IR and HRMS spectroscopy. They were synthesized from a variety of starting materials
purchased from Sigma-Aldrich according to modified procedures described in Sproat, 1994
[22]. Nucleoside 2 is a known compound and spectra from the other two compounds are avail-
able from the authors. Stock solutions (20 mM) of the test nucleosides were prepared in tissue
culture grade DMSO.
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Data analysis and statistics
All the data was analysed and dose response curves constructed using Graph-Pad Prism ver-
sion 5. Differences between controls and nucleoside treated samples were tested for significance
with the Prizm3 Instat software package, using analysis of variance (ANOVA) and the Stu-
dent’s-t test with a significance threshold set at p< 0.05.
Results
Nucleoside analogues are cytotoxic to HT-29 and Caco-2 cells
Three novel pyrimidine ribonucleoside analogues were identified in a screening procedure of
twenty three novel nucleosides as having cytotoxic activity against both HT-29 and Caco-2 cell
lines when tested at a concentration of 100 μM. The structures of the three active nucleosides
are shown in Fig 1A. Nucleoside 1 and 2 were uridine analogues and nucleoside 5 was a
Fig 1. Structures of the active nucleoside analogues (A), their respective IC50 values compared to camptothecin, in the Caco-2 and HT-29 cell lines
(B), and (C) the leucocyte survival bargraph. (B) The bars represent the mean ± SEM of the IC50 values from four MTT assays carried out for each
test nucleoside. The HT-29 and Caco-2 cells were exposed to the nucleoside analogues at concentrations ranging from 1 μM to 120 μM. Normal
peripheral leukocytes (C) were exposed to 100 μM of nucleoside 1, 2, 5 and camptothecin for 24 hrs.
doi:10.1371/journal.pone.0138607.g001
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cytidine analogue. The pyrimidine bases were linked via an N-glycosidic bond to carbon 1 of
the ribose sugar. All three molecules were substituted with bulky phenyl groups on carbon 5 of
the ribose sugar. Nucleoside 1 had a C-O linkage with a 4,4-dimethoxytrityl group and nucleo-
sides 2 and 5 were linked to a tert-butyldiphenyl group via a stable Si-O bond. The nucleosides
were arbitrarily numbered one to twenty-three and test nucleosides number one, two and five
were found to be active in the initial screening assays.
The fifty percent inhibitory concentration (IC50) values were obtained for the three active
nucleosides and are shown in Fig 1B. The two cell lines displayed differential sensitivity to the
three active test compounds and to camptothecin. HT-29 cells were more sensitive to camp-
tothecin than Caco-2 cells, with an IC50 value of 5.7 μM compared to 10.6 μM, respectively.
Nucleoside 5 was the most effective against HT-29 cells with an IC50 value of 3.4 μM and
showed similar activity to the Caco-2 cells with an IC50 value of 4.8 μM. In HT-29 cells, nucleo-
side 1 and 2 had IC50 values 6.4 and 3.4 times higher than that of camptothecin, displaying
IC50 values of 36.3 and 19.1 μM, respectively. This is in contrast with the Caco-2 cells, where
nucleoside 1 had similar activity to camptothecin and nucleoside 2 was 3 times more active
than camptothecin, with an IC50 value of 3.5 μM. Representative dose response curves are
shown in S1 Fig
Exposure of freshly isolated leukocytes to each of the three nucleoside analogues and to
camptothecin, respectively indicated that nucleoside 2 had the greatest inhibitory effect on the
leukocytes, causing a 38.5% decrease of leucocyte viability at a concentration of 100 μM. This
was two-fold lower than the effect of camptothecin on the leukocytes. Nucleoside 1 and nucleo-
side 5 were the least toxic to the leukocytes, with cell viability being maintained at 82.7% and
99.9%, respectively (see Fig 1C).
Nucleosides induce caspase 8 and caspase 3 activity
Caspase 8 is an initiator caspase which causes cleavage and activation of effector caspases, such
as caspase 3. Fig 2 shows caspase 8 and caspase 3 activity determined at various time intervals,
following the addition of the test nucleosides, to both cell lines. The three nucleosides caused
an increase in caspase 8 and caspase 3 activity in both cell lines relative to the negative control.
However, with the exception of nucleoside 2, the caspase activity was not as high as that
induced by camptothecin. Nucleoside 2 was the most effective inducer of caspase activity in
both cell lines, inducing caspase 8 and 3 activity to a similar level as camptothecin. However, in
both the HT-29 and Caco-2 cell lines, the induction of maximal caspase 8 and 3 activity took
longer to achieve (12 hours as opposed to 2–4 hours). Importantly, the activity of both caspases
declined at a slower rate than that of the camptothecin treated cells, remaining higher than
camptothecin after 24 hours of exposure.
Nucleosides have a minimal effect on mitochondrial membrane potential
(Δψm)
The Δψmwas measured by flow cytometry with the cationic fluorescent dye JC-1. The percent-
ages of Δψm in the nucleoside treated HT-29 and Caco-2 cells compared with the negative and
positive control cells are summarized in Table 1. Compared to the negative control, in the HT-
29 cells, nucleoside 2 and 5 had a marginal (< 3%) effect on the Δψm. Nucleoside 1 treatment
resulted in 4% of cells with a decreased Δψm above that of the control. In contrast, camptothe-
cin treated cells had 34.8% of cells with a decreased Δψm compared to the control. In the Caco-
2 cells, nucleosides 1 and 5 affected some 17% of cells resulting in a decreased Δψm, while
nucleoside 2 had a marginal effect (< 3%) above that of the control. This is in contrast with
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Fig 2. Active nucleosides induce caspase 3 and caspase 8 activity in both HT-29 (A) and in Caco-2 (B)
cells after various exposure periods to 100 μM camptothecin (a), nucleoside 1 (b), nucleoside 2 (c),
and nucleoside 5 (d) Data points on the graphs represent the mean of the triplicate values of caspase
activity after cells were exposed to the nucleoside analogues for the indicated time periods.
doi:10.1371/journal.pone.0138607.g002
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camptothecin which caused 34.6% cells with a Δψm in the Caco-2 cells. Scattergraphs are
shown in supplementary S2 Fig.
Nucleosides alter intracellular cytochrome c distribution
In cells, between 90 and 100% of total cellular cytochrome c is normally located within the
mitochondria. Fig 3A and 3B show that the test nucleosides increased the cytosolic cytochrome
c fraction for both cell lines relative to the negative control, but not to the same extent as camp-
tothecin. In the HT-29 cells, nucleoside 2 caused the highest percentage of cytochrome c to
relocate to the cytosol (75.35±1.15%), albeit lower than that of camptothecin (85.19±1.54%).
Nucleosides 1 and 5 caused some 68.22±0.62% and 70.42±0.62% of cytochrome c to relocate to
the cytosol, respectively.
In the Caco-2 cells, nucleoside 5 caused the highest percentage of cytochrome c to shift to
the cytosol (70.42±1.76%), which is lower than that of camptothecin (86.94±1.72%). The effects
of nucleosides 1 and 2 were comparable to nucleoside 5 with cytosolic cytochrome c fractions
of 63.87±2.03% and 68.23±0.62%, respectively. The results thus indicate that treatment with
the nucleoside analogues caused a decrease in mitochondrial cytochrome c and concomitant
increase in cytosolic cytochrome c.
Annexin V binding increases in HT-29 and Caco-2 cells
The flow cytometric assay for annexin V-FITC, indicates that apoptosis was induced after addi-
tion of the active nucleoside analogues to both cell lines, as shown in Table 2 and S3 Fig. After
24 hours of exposure to the nucleoside analogues or camptothecin, there were primarily two
populations of cells: viable, non-apoptosing cells (annexin V-FITC and PI negative) and cells
undergoing apoptosis (annexin V-FITC positive and PI negative). A small population of cells
were observed to be annexin V-FITC and PI positive, indicating that they were in end-stage
apoptosis or necrosis.
The percentage of each subpopulation of cells in both cell lines exposed to the nucleoside
analogues is shown in Table 2. In the HT-29 cells, nucleoside 1 was the most effective apoptotic
inducer, with 38.4% of the cells being detected in early apoptosis and 5.9% of cells in late apo-
ptosis/necrosis. While superior to camptothecin for early apoptosis, camptothecin treatment
nevertheless caused some 19.6% of cells to shift to late apoptosis/necrosis. This indicates that
camptothecin was able to induce apoptosis at a faster rate than the nucleosides. Nucleoside 2
Table 1. Summary of the mitochondrial membrane potential change induced by the nucleoside analogues and camptothecin in the HT-29 and
Caco-2 colon cancer cell lines.
Percentage cells with unchanged
Δψm
Percentage cells with depolarized
Δψm
Cell type HT-29 Caco-2 HT-29 Caco-2
Untreated cells 88.44 92.58 10.35 7.47
Nucleoside 1 79.55 75.64 14.39 24.33
Nucleoside 2 87.02 89.46 12.74 10.38
Nucleoside 5 87.53 75.68 12.12 23.96
Camptothecin 53.59 57.96 44.00 40.88
The table shows the percentage of HT-29 and Caco-2 cells with a depolarized ΔΨm and an unchanged ΔΨm after exposure to the nucleoside analogues
at a concentration of 100 μM for 24 hours.
doi:10.1371/journal.pone.0138607.t001
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treatment resulted in 20.5% of cells being in early apoptosis and 10.6% in late apoptosis. Nucle-
oside 5 had 22.2% cells in early apoptosis and 2.3% cells in late apoptosis/necrosis.
Fig 3. Nucleosides 1, 2 and 5 cause the redistribution of cytochrome c frommitochondria to the cytosol in HT-29 (A) and Caco-2 (B). The cells were
exposed to 100 μM of nucleoside 1, 2, 5 and camptothecin, respectively, for 24 hours. The bars represent the mean ± SEM from three Elisa assays carried
out for each nucleoside.
doi:10.1371/journal.pone.0138607.g003
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The effects were different in the Caco-2 cells, all three nucleosides showed a similar percent-
age of viable cells, ranging from 61 to 66.3%. Nucleoside 5 was the most effective with 30.9% of
cells being detected in early apoptosis and 4.8% in late apoptosis or necrosis, whereas after
nucleoside 1 treatment, 17.4% of cells were in early apoptosis and 14.8% in late apoptosis.
Some 21.7% cells were detected in early apoptosis and 11.4% of cells in late apoptosis/necrosis
following nucleoside 2 treatment. Scattergraphs are shown in S3 Fig.
The nucleosides fail to induce caspase 9 activity
The ability of the test nucleosides to stimulate caspase 9 activity was determined after cells
were exposed to 50 μM of each nucleoside for 24 hrs. Camptothecin (20 μM) was used as a pos-
itive control and was able to stimulate caspase 9 activity, in contrast with the three nucleosides
as shown in S4 Fig.
Nucleosides do not affect the expression of Bcl-2 and Bax
In order to gain more information regarding the redistribution of cytochrome c to the cyto-
plasm without a prominent change in mitochondrial membrane potential, we investigated the
expression of Bcl-2 and Bax in the HT-29 and Caco-2 cell lines and their response to nucleo-
side treatment. Cells were exposed to 50 μM nucleosides for 6 hours.
Bcl-2 is strongly expressed and associated with the nucleus in both HT-29 and Caco-2
cells. In untreated and treated HT-29 cells, Bcl-2 was expressed with a strong fluorescent sig-
nal and associated with the nucleus (S5 Fig). This was confirmed by merging Hoechst and Bcl-
2 images which presented a pink merged image indicating co-localisation of the two fluoro-
chromes. Exposure to the test nucleosides had no obvious effect on Bcl-2 expression levels or
its subcellular distribution. Caco-2 cells similarly, had a predominantly nuclear distribution of
Bcl-2. However some cells emitted a much weaker signal than others (S6 Fig). Exposure to
nucleoside 1 and 2 caused minimal redistribution of Bcl-2 to the perinuclear space which was
not observed with nucleoside 5 treatment.
Bax is poorly expressed in HT-29 and Caco-2 cells with a perinuclear distribution. In
HT-29 control cells, Bax was sparsely associated with the nuclei with a predominantly perinuc-
lear distribution (S7 Fig). Hoechst/Bax merged images support the observation that Bax has a
perinuclear distribution. Noteably, the fluorescent intensity of Bax was much lower than that
of Bcl-2 indicating comparatively lower expression levels. Exposure to the three nucleosides
showed a small increase in Bax fluorescence compared to that of the control. In addition, treat-
ment with nucleoside 5, caused a polarised nuclear clustering of Bax (S7 Fig). The Hoechst/Bax
merged image shows an increase in pink fluorescence indicating an increased association of
Bax with the nucleus.
Table 2. Percentage of HT-29 and Caco-2 cells in early and late apoptosis as determined by the annexin-V assay.
Percentage viable cells Percentage early apoptotic
cells
Percentage late apoptotic /
necrotic cells
HT-29 Caco-2 HT-29 Caco-2 HT-29 Caco-2
Untreated control 86.47 79.06 4.28 7.34 3.22 0.18
Nucleoside 1 55.08 61.38 38.41 17.42 5.94 14.84
Nucleoside 2 68.39 66.34 20.52 21.68 10.58 11.41
Nucleoside 5 74.53 62.59 22.26 30.95 2.33 4.83
Camptothecin 47.95 50.18 27 27.06 19.64 17.78
doi:10.1371/journal.pone.0138607.t002
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Expression and cellular distribution of Bax was similar in Caco-2 cells (S8 Fig). Bax expres-
sion was low in Caco-2 cells and images had to be enhanced to show the subcellular distribu-
tion. It was therefore not possible to determine if the nucleosides had a direct effect on Bax
expression levels or its subcellular distribution in Caco-2 cells.
Effects of the nucleosides on cell morphology
Hoechst staining identifies apoptotic nuclei. In HT-29 cells, both nucleoside 1 and 2
were able to induce apoptosis as reflected by the specific nuclear staining pattern (indicated
with a solid/block arrow in Fig 4). The nuclei of untreated control cells were typically oval in
shape, staining blue with a uniform distribution of the dye. In contrast, the nucleoside 5 treated
cells that remained attached to the growth surface after 20 hours, demonstrated irregularly
shaped nuclei (Fig 4), indicating that the cell nucleus may be a possible target. In addition,
these cells showed a high degree cytoplasmic vacuolisation (Fig 4), indicating an extensive cyto-
plasmic effect.
Untreated Caco-2 cells showed the typical oval nuclear structure with even dye distribution
when stained with Hoechst (Fig 5). Staining of treated Caco-2 cells did not demonstrate a dis-
tinct apoptotic nuclear staining pattern as seen for nucleoside 1 and 2 in HT-29 cells. However,
those cells that remained attached to the growth surface contained contracted nuclei with
increased fluorescence intensity, indicating a pre-apoptotic state. Perinuclear vacuole forma-
tion was a prominent feature of both nucleoside 1 and 2. While nucleoside 1 did not have an
obvious effect on the nuclei of treated cells, the nuclei of cells treated with nucleoside 2
appeared to be contracted. The increased fluorescence intensity observed for these nuclei is
indicative of a pre-apoptotic state. In contrast, the nuclei of cells exposed to nucleoside 5
showed variation in the sizes of the nuclei, irregular staining of the nuclei and the presence of
small nuclear buds as indicated by white arrows in Fig 5.
Nucleoside 1 and 2 cause rapid vacuole formation. In the HT-29 cells, nucleoside 1 and
2 caused the appearance of perinuclear vacuoles as soon as two hours post-exposure (solid/
block arrows in Fig 6). At this time, the nucleus and nuclear structure appeared to be intact. At
four hours, nucleoside 1 caused an increase in size and number of the vacuoles, while a loss of
cell adherence to the growth surface was a prominent effect of nucleoside 2, as indicated by the
curved arrow (Fig 6). At six to eight hours, nucleoside 1 caused some cells to detach from the
culture surface and form an unusual multi-lobular structure (chevron in Fig 6). Cells that
remained attached showed a loss of nuclear definition and a change in the nuclear shape
together with a loss in the resolution of the nucleoli. A similar trend was observed for nucleo-
side 2, except that the process was accelerated with a large percentage of cells detaching from
the growth surface from 4 hours onwards (curved arrow in Fig 6). The cells appeared rounded
at eight hours with numerous multi-lobular cells and smaller rounded structures (white chev-
ron in Fig 6) being present.
In Caco-2 cells, the morphological changes were similar to that of HT-29 cells with the
exception being the rate at which the various changes occurred. Perinuclear vacuole formation
was observed within 1 hour of exposure (Fig 7) and was a prominent feature of Caco-2 cells
exposed to nucleoside 1 and 2 (Fig 7). The appearance of the multi-lobular cell structures (indi-
cated by a chevron) was evident from two hours onwards for nucleoside 2 and from 4 hours
onwards for nucleoside 1 and 5. As seen in Fig 7, in Caco-2 cells, nucleoside 2 treatment did
result in the loss of cell adherence to the growth surface, as it did in HT-29 cells.
In cell culture, apoptotic cells detach rapidly from the growth surface and disintegrate in the
culture medium. It is therefore not always possible to observe a high apoptotic index (cells with
fragmented nuclei) in in vitro cultures. However, Hoechst staining of detached Caco-2 cells
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indicate that a high percentage of cells were apoptotic. Notably, multi-lobular cells were fre-
quently observed in the nucleoside treated cultures of both Caco-2 and HT-29 cells, and may
Fig 4. In HT-29 cells, nucleoside 1 and 2 induce nuclear fragmentation, while nucleoside 5 causes a loss of normal nuclear structure and
cytoplasmic vacuolisation. Cells were exposed to 50 μM of nucleoside 1, 2 and 5 for 24 hours and stained with Hoechst 33342 stain. Scalebar: 20 μm.
doi:10.1371/journal.pone.0138607.g004
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Fig 5. In Caco-2 cells, nucleoside 1 and 2 cause perinuclear vacuole formation, while nucleoside 5 causes a loss of normal nuclear structure,
nuclear budding and cytoplasmic vacuolisation. Cells were exposed to 50 μM of nucleoside 1, 2 and 5 for 24 hours and stained with Hoechst 33342 stain.
Scalebar: 20 μm.
doi:10.1371/journal.pone.0138607.g005
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Fig 6. Nucleoside-inducedmorphological changes in HT-29 cells include rapid perinuclear vacuole formation (nucleoside 1 and 2) and a loss of
cellular adherence (nucleoside 5). Cells were exposed to 50 μM of the nucleoside for the indicated time periods. Experiments were repeated three times.
Scale bar: 20 μm.
doi:10.1371/journal.pone.0138607.g006
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well represent an apoptotic cell prior to disintegration (Fig 8B). The formation of these struc-
tures, while more plentiful in the treated Caco-2 cells, was also observed in the HT-29 cells.
Nucleoside 5 damages intracellular junctions. In contrast, HT-29 cells exposed to nucle-
oside 5, showed a rapid change in the integrity of the intra-cellular junctions and a rapid loss of
nuclear definition (solid triangle, Fig 6). The formation of filopodia was evident at two hours.
At eight hours, a large percentage of cells remained loosely attached to the growth surface by
extended filopodia (rounded arrows) and showed a distinct loss of normal cellular morphology.
Although vacuole formation was not obvious in the cells exposed to nucleoside 5 for six hours,
an exposure period of 24 hours revealed extensive vacuole formation in the cells remaining
Fig 7. Nucleoside-inducedmorphological changes in Caco-2 cells include rapid perinuclear vacuole
formation (nucleoside 1 and 2) and a loss of cellular adherence (nucleoside 5). Cells were exposed to
50 μM of each nucleoside for the indicated times and the experiments were repeated three times. Scalebar:
20 μm.
doi:10.1371/journal.pone.0138607.g007
Fig 8. Nucleoside 2 treated vacuolated HT-29 and Caco-2 cells stained with acridine orange shows an absence of lysosomal staining (A) and a
nucleoside 2 induced HT-29 multi-lobular structure (B). Acridine orange stained HT-29 and Caco-2 cells, following exposure to 50 μM of nucleoside 2 (A).
HT-29 cells were exposed to 50 μM of nucleoside 1 and the supernatant harvested and centrifuged at 500 x g for 5 mins. The multi-lobular cell was stained
with Hoechst 33342 and acridine orange (B). Scalebar: 20 μm.
doi:10.1371/journal.pone.0138607.g008
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attached to the growth surface, shown in Fig 8A. Hoechst and acridine orange staining revealed
that the multi-lobular cells had fragmented nuclei and may well present a late apoptotic cell
(Fig 8B). These structures were frail and rapidly disintegrated in the cell culture media.
Caco-2 cells responded in a similar fashion to nucleoside 5 which caused a rapid change in
the shape of the cells, with the loss of cellular junctions (rounded arrow, Fig 7), 1 hour post
treatment. This alteration in cell-cell contacts progresses rapidly, with a high percentage of
cells being non-adherent after six hours (Fig 7). The remaining adherent cells display altered
morphology with both nuclear and cytoplasmic changes (solid triangles, Fig 7).
Nucleoside 5 causes actin aggregation. Since phalloidin binds to F-actin and may provide
clues regarding cytoskeletal changes induced by the nucleosides, nucleoside treated cells were
incubated with a phalloidin-FITC conjugate. Nucleoside 5 induced a marked change in the
subcellular distribution of actin in HT-29 cells but not in Caco-2 cells (Fig 9). In HT-29 cells
actin aggregated in clusters (arrow in Fig 9) which were distributed throughout the cytoplasm
and in some cells was associated with the distorted nucleus (solid triangle in Fig 9). Despite the
fact that the cytoskeleton was affected, there was an aggregation of actin at the remaining inter-
cellular junctions (Fig 9). Nucleoside 1 and 2 treatment did not cause any changes in actin dis-
tribution in either HT-29 or Caco-2 cells.
Vacuoles and autophagy
Vacuoles lack autophagic features. In order to determine the nature of the vacuoles
observed under phase contrast microscopy, nucleoside 2 treated cells were first stained with
acridine orange, an indicator of acidic structures, including lysosomes and autophagosomes.
Since no organelles were stained bright orange/red with acridine orange, (Fig 8A), it is unlikely
that such vacuoles were autophagic in nature. The non-autophagic nature of these vacuoles
was subsequently confirmed by staining nucleoside treated cells with monodansylcadaverine
(Fig 10). Analysis of phase contrast and MDC labelled merged images, revealed that these vacu-
oles do not co-localize with the MDC granules, thus indicating their non-autophagic nature
(Fig 10). Moreover, the vacuoles appeared to be fluid-filled and not surrounded by membranes
filled with cytoplasm, as would be expected for autophagic vacuoles.
Nucleoside 2 and nucleoside 5 induce the formation of autophagic vacuoles. The ques-
tion regarding autophagy was further investigated using MDC, an indicator for autophagic vac-
uoles. Chloroquine was used as a positive control. In Caco-2 cells, both chloroquine and
nucleoside 2 showed a similar pattern of MDC fluorescence of round larger, and brightly fluo-
rescent granules with a perinuclear distribution (arrows, Fig 11). The diameter of these gran-
ules varied between 2 and 5 μm as measured by the CellSense software. Small punctate
fluorescent granules (less than 1 μm in diameter) and diffuse fluorescence was also present in
the cytoplasm surrounding the nucleus. In the control, nucleoside 1 and camptothecin treated
cells, small punctate fluorescent granules (<1μm) and diffuse fluorescence showed a perinuc-
lear distribution. Nucleoside 5 caused the formation of larger fluorescent granules, similar in
size to the chloroquine induced granules, but with a decreased fluorescence intensity. These
granules co-localized with the dark granules visualized under phase contrast.
Analysis of the merged images revealed that the larger, highly fluorescent granules of the
chloroquine and nucleoside 2 treated cells do not always co-localize with the vacuoles seen
under phase contrast (Fig 10). In the case of nucleoside 2, the bright fluorescent granules co-
localized with the prominent phase contrast observed vacuoles. Closer inspection of phase con-
trast images show that these vacuoles appear to be surrounded by membranes, unlike the vacu-
oles that do not co-localize with the fluorescent granules. In chloroquine treated cells there was
poor co-localisation of phase contrast visualised vacuoles and fluorescent granules (Fig 11).
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Fig 9. Nucleoside 5 causes aggregation of actin in HT-29 cells, but not in Caco-2 cells. Cells were
treated with 50 μM of nucleoside 5 for 6 hours. Scalebar: 20μm.
doi:10.1371/journal.pone.0138607.g009
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Fig 10. Vacuoles observed under phase contrast microscopy do not co-localize with MDC stained
fluorescent granules. HT-29 cells were exposed to 50 μM of nucleoside 2 for 3 hours before MDC staining.
doi:10.1371/journal.pone.0138607.g010
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Fig 11. Nucleoside 2 and chloroquine cause the formation of large, highly fluorescent autophagic vacuoles in Caco-2 cells.Cells were exposed to
nucleoside 1, 2 and 5 at a concentration of 50 μM for three hours. Chloroquine (50 μM) was used as a positive control and camptothecin (20 μM) was
included as a vacuole negative control. Arrows indicate autophagic vacuoles. Scalebars: 20 μm.
doi:10.1371/journal.pone.0138607.g011
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A similar pattern was observed when HT-29 cells were treated with the nucleosides, chloro-
quine and camptothecin, (Fig 12). Control cells display diffuse and small punctate perinuclear
fluorescent granules less than 1 μm in diameter. Nucleoside 1 was similar to the control, but
with an increased fluorescence intensity, especially in cells where numerous small vacuoles
were visualized with phase contrast microscopy. Nucleoside 2 and chloroquine treated cells dis-
played a similar increase in larger (2–5 μm diameter) intensely fluorescing granules, as well as
smaller punctate fluorescent granules concomitant with a decrease in the diffuse cytoplasmic
fluorescence. In HT-29 cells the large fluorescent granules and dark granules observed under
phase contrast co-localized when exposed to nucleoside 2 (Fig 12). In cells showing this
increased granular fluorescence the diffuse fluorescence was decreased and fewer punctate
fluorescent granules were present. Small punctate fluorescent granules that concentrated
around the nucleus were observed in the camptothecin treated cells. Nucleoside 5 treated HT-
29 cells had a similar staining pattern to Caco-2 cells with larger granules showing less intense
fluorescence compared to chloroquine and nucleoside 2 treatment (Fig 12).
Discussion
Nucleoside analogues are an important class of chemotherapeutic agents used in the treatment
of cancer and viral infections [23, 24, 25]. This study identified novel nucleoside analogues that
proved to be cytotoxic and able to induce an unusual apoptotic response with the concurrent
formation of cytoplasmic vacuoles in two colorectal adenocarcinoma cell lines. Importantly,
they demonstrated a sparing effect on normal leukocytes which may translate to a clinically
beneficial outcome. Camptothecin, a mammalian topoisomerase I inhibitor, was used as a posi-
tive control and is a known inducer of apoptosis, mediating its activity via both the death
receptor and the mitochondrial pathway [26, 27].
In Caco-2 cells, the compounds displayed similar or better cytotoxic effects when compared
to camptothecin. Only nucleoside 5 displayed superior activity to camptothecin in HT-29 cells.
However, all the compounds were comparable to camptothecin in their ability to induce apo-
ptosis. Importantly, at a concentration of 100 μM, they were considerably less toxic than camp-
tothecin to normal leukocytes, which indicates some degree of selectivity towards cancer cells.
Nucleosides 1 and 5 showed the least toxicity towards leukocytes, with the percentage cell via-
bility being 82 and 99%, respectively. Although nucleoside 2 was the most toxic decreasing the
viability to 60%, it was nevertheless lower than camptothecin, which reduced leucocyte viability
to 34%. The decreased toxicity to leukocytes is a positive indicator for cancer cell selective tox-
icity, since most nucleoside based chemotherapeutic agents are toxic to leukocytes and an indi-
cator of an unfavourable adverse effect profile.
The structures of the three nucleosides (Fig 1A) are such that they cannot undergo phos-
phorylation to the active triphosphate form, which is a substrate requirement for binding to
DNA and RNA polymerase and for the subsequent incorporation into DNA or RNA strands,
or the inhibition of the respective polymerase enzymes. It is however possible, that nucleoside
one and two may have compromised the activity of other enzymes required in nucleoside pro-
cessing, such as thymidylate synthase and ribonucleotide reductase. Since nucleoside 1 and 2
have a uridine base they may bind and interfere with the action of thymidylate synthase which
is required for the conversion of uridine to thymidine. All three compounds can potentially
interfere with the action of ribonucleotide reductase which is responsible for converting ribo-
nucleotides to deoxyribonucleotides [28]. Compromised activity of these two enzymes may
explain the cytotoxic and apoptotic effects observed in this study.
Activation of caspase provides evidence of the induction of apoptosis [29, 30]. The impaired
expression and function of caspase 8 promotes tumour formation, progression and treatment
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Fig 12. Nucleoside 2 and chloroquine cause the formation of large highly fluorescent autophagic vacuoles in HT-29 cells.Cells were exposed to
nucleoside 1, 2 and 5 at a concentration of 50 μM for three hours. Chloroquine (50 μM) was used as a positive control at and camptothecin (20 μM) was
included as a negative control. Arrows indicate autophagic vacuoles. Scalebars: 20 μm.
doi:10.1371/journal.pone.0138607.g012
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resistance in several types of cancers [29]. Caspase 3, the key executioner of apoptosis, is
responsible for the proteolysis of proteins essential for DNA repair such as caspase activated
DNase (CAD) and poly-(ADP-ribose) polymerase (PARP). Upon activation of the extrinsic
pathway of apoptosis, it is expected that caspase 8 activation occurs before the activation of cas-
pase 3 [29, 31].
This study showed that the sequential activation of caspase 8 and caspase 3 was induced by
all three nucleosides and camptothecin, in both the HT-29 and Caco-2 colorectal cell lines.
Since both caspase 8 and caspase 3 were activated, this suggests the involvement of the death
receptor pathway. Nucleoside 2 was the most potent compound and induced caspase 3 activity
in HT-29 and Caco-2 cells to a similar level as camptothecin, albeit at a slower rate (8 hours
versus 2 hours for caspase 8 activity and 12 hours versus 4 hours for caspase 3 activity). Further-
more, in both cell lines, the increase in caspase 8 and caspase 3 activity was sustained for a lon-
ger period of time compared to that of camptothecin. Although nucleoside 2 showed higher
caspase activity relative to the other nucleosides, it displayed a lower cytotoxic effect than
camptothecin on the HT-29 cell line, with an associated IC50 value of 19.1±2.7 μM; but with a
potent IC50 value of 3.5±0.9 μM in the Caco-2 cell line. The higher IC50 values observed for
HT-29 cells while not consistent with the observed apoptotic effects, may have been as a result
of a slower onset of mitochondrial toxicity. The MTT assay measures the integrity of mito-
chondrial function and it is possible that mitochondrial dysfunction manifested later than the
measured apoptotic markers [32]. Fluorescence microscopy using Hoechst DNA stain showed
that the HT-29 cells displayed a high apoptotic index when exposed to nucleoside 2. This is
consistent with the increased in caspase 8 and 3 activity. Compared to the control, nucleosides
1 and 5 induced caspase 8 and 3 activation in both cell lines, albeit lower than camptothecin
and nucleoside 2, indicating their ability to induce apoptosis. Apoptotic nuclei were readily
observed in HT-29 cells treated with nucleoside 1 and 2.
The annexin-V assay, being a measure of the percentage cells that have phosphatidylserine
exposed on the outer leaflet of the cell membrane, provides further evidence that the test nucle-
osides were able to induce apoptosis in both the HT-29 and Caco-2 cells. Externalization of
phosphatidylserine occurs in early apoptosis [33]. Although nucleoside 2 showed maximal cas-
pase activity for both cell lines, fewer cells stained for early and late apoptosis when compared
to camptothecin. Nucleoside 1 was the most effective in HT-29 cells, whereas nucleoside 5 was
the most effective in Caco-2 cells. This indicates some selectivity in terms of phosphatidylserine
translocation. Camptothecin treated cells showed the highest percentage of cells in late apopto-
sis/necrosis indicating its ability to induce apoptosis rapidly. The apparent slower induction of
phosphatidylserine translocation in the presence of test nucleosides may be attributed to the
intrinsic dysregulation and abnormalities of the apoptotic pathways in colorectal cancer cells
[2, 5].
The extrinsic pathway of apoptosis is induced by the interaction between the ‘death ligands’
and ‘death receptors’, subsequently resulting in the activation of caspase 8. When death ligands,
including TRAIL and FAS, bind to the death receptors, such as the TRAIL receptor and CD95,
the death-inducing signalling complex (DISC)-protein complex is formed. The formation of
DISC is followed by the activation of caspase 8, which sequentially activates caspase 3 to initiate
apoptosis [3]. Previous studies have shown that the expression of FasL is upregulated in colon
cancer [34]. Since the novel nucleoside analogues induced caspase 8 activity in both the HT-29
and Caco-2 cells, it may be reasonable to deduce that the novel nucleosides induced apoptosis
via the extrinsic pathway.
Mitochondria play a central role in intrinsic apoptotic signalling [35]. Disruption of the
mitochondrial membrane potential (Δψm) and the translocation of cytochrome c from the
mitochondria are early markers of apoptosis [36, 37]. Compared to camptothecin, the
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nucleoside analogues caused a small decrease in the Δψm of both cell lines. Therefore, the
major changes observed in the cellular distribution of cytochrome c were unexpected. In the
Caco-2 cells, the three test nucleosides 1, 2 and 5 respectively, caused an 8, 8.8 and a 9-fold
increase of cytoplasmic cytochrome c levels, respectively, compared to the untreated control.
Camptothecin caused the greatest increase in cytosolic cytochrome c, with an 11.2 fold increase
above the untreated control. A similar pattern was observed for HT-29 cells; test nucleoside 1,
2 and 5 respectively, caused a 7.4, 8.1 and a 7.7 fold increase in cytosolic cytochrome c com-
pared to the untreated control, but not as high as camptothecin (9.2 fold). Thus, the release of
cytochrome c from mitochondria in the HT-29 and Caco-2 cells after treatment with the nucle-
oside analogues, appears to occur by a mechanism that does not include mitochondrial depo-
larization. A decrease in mitochondrial membrane potential is thought to be a prerequisite for
the release of cytochrome c [38]. Therefore, the results from this study indicate that the two
events were not associated. In support of this, there are several reports in the literature that
confirm that the release of cytochrome c is not always linked to a change in the mitochondrial
membrane potential [37, 39].
In order to better understand the unusual mitochondrial effects, we investigated the expres-
sion of Bcl-2 and Bax in both cell lines using immunofluorescence microscopyand, evaluated
the expression levels of each of the two proteins, following nucleoside treatment. Bax (Bcl-2-
associated X protein) and Bak (Bcl-2-antagonist killer) are two important pro-apoptotic Bcl-2
proteins [40]. Bax is normally present in the cytosol of living cells and translocates to the mito-
chondria during apoptosis due to the up-regulation of the tumour suppressor protein, p53 [41,
42]. However, in Caco-2 cells, p53 is not expressed [43], whereas HT-29 cells contain a mutated
form of p53 (point mutation R273H), which may influence its functionality and its effects on
Bax and Bcl-2 [43, 44]. It is therefore possible that the increase in cytosolic cytochrome c is not
associated with Bax/Bak mitochondrial pore formation and occurs independently of p53.
Our results indicate that in both cell lines Bcl-2 is strongly expressed and is associated with
the nucleus, while Bax showed lower expression levels and is located primarily in the perinuc-
lear space which is consistent with a mitochondrial association. In both cell lines, exposure to
the nucleosides did not reveal any marked changes in subcellular location or expression levels
of either Bcl-2 or Bax (S5–S8 Figs).
Despite the fact that Bcl-2 is generally believed to be an anti-apoptotic protein, some studies
have shown that Bcl-2 can also function in a pro-apoptotic manner [45]. Portier and Tagliala-
tela [46] proposed that the ability of Bcl-2 to function as either pro-or anti-apoptotic is depen-
dent on its subcellular location. Bcl-2 associated with the mitochondrial membrane binds to
Bax and prevents the formation of homo-dimers responsible for mitochondrial pore formation
[47]. The mechanism and proteins involved in nuclear Bcl-2 mediated apoptosis remains unex-
plored. This study provides indirect support for the idea that nuclear associated Bcl-2 may be
pro-apoptotic. The strong expression of nuclear Bcl-2 combined with the lower expression of
Bax offers an explanation for the induction of apoptosis in the absence of mitochondrial mem-
brane depolarisation.
Caspase 8 has been shown to have an important role in the feedback loop of effector caspase
activation and cytochrome c release. Bid, a pro-apoptotic Bcl-2 protein, is a substrate of caspase
8. When caspase 8 cleaves Bid, the truncated Bid (tBid) is able to activate Bax to form Bax mul-
timers in the mitochondria, thereby leading to the release of cytochrome c independently, with
a resultant change in the mitochondrial membrane potential [48,49,50]. This process, never-
theless still requires a loss of mitochondrial membrane potential and the formation of Bax mul-
timers. The lack of a mitochondrial membrane potential loss and the low Bax expression levels
does not support the notion that caspase 8 is responsible for cytochrome c translocation and
the activation of the intrinsic apoptotic pathway.
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The release of cytochrome c from the mitochondria triggers the activation of caspase 9 in a
complex with dATP and Apaf-1 to form the apoptosome. Considering this, we evaluated the
ability of the nucleosides and camptothecin to induce caspase 9 activity. Campothecin was able
to induce caspase activity, whereas the three test nucleosides were not. The lack of caspase 9
activation by the test nucleosides in both cell lines indicate that the classical intrinsic pathway
is not induced by the test nucleosides.
The microscopic evaluation of the changes in cell morphology may however provide a clue
to the increased cytoplasmic cytochrome c levels. All three nucleosides were able to induce
extensive cytoplasmic vacuole formation, although a slower process for nucleoside 5. Cyto-
plasmic vacuolisation is not usually associated with apoptosis, but rather with non-apoptotic
cell death and/or autophagy [51]. Initial morphological studies indicated the absence of
orange/red staining of the vacuoles with acridine orange. Furthermore, their size and perinuc-
lear localisation indicate that they are not likely to be autophagic in nature. In addition, the vac-
uoles appeared to be fluid filled lacking either cytoplasm or cytoplasmic organelles, as is
expected in autophagy.
In order to analyse the nature of the vacuoles, cells were incubated with MDC, a marker for
autophagic vacuoles. Chloroquine, a known inducer of autophagic vacuole formation in differ-
ent cell types, was used as a positive control [17, 18]. MDC accumulates in autophagic vacuoles
once the autophagosomes have fused with lysosomes [19, 20, 21]. It also labels acidified endo-
somes and lysosomes [19]. Nucleoside 2 and chloroquine caused the formation of distinct,
highly fluorescent granules. The punctate smaller granules observed with controls, nucleoside
1 and camptothecin are assumed here to be lysosomal in nature. Importantly, the larger highly
fluorescent granules did not co-localize exclusively with the vacuoles observed under phase
contrast, but rather with the dark granules (Fig 10). This indicates that the vacuolisation
induced by these compounds are neither acidic nor autophagic in nature and supports the
observations made using acridine orange (Fig 8). In addition the results obtained provide pre-
liminary evidence for the induction of autophagy by nucleoside 2 and possibly nucleoside 5, in
both cell lines. Though an investigation of autophagic flux is beyond the scope of the present
study it will provide valuable information regarding the type of cell death and the implications
of autophagic vacuole formation induced by these compounds. It is of particular interest that
despite their similarity of chemical structure, only nucleoside 2 and 5 caused the distinct for-
mation of potentially autophagic vacuoles.
Autophagy, can however explain the increase in cytoplasmic cytochrome c, since mitochon-
dria are degraded in autophagosomes resulting in an increase in cytoplasmic cytochrome c.
This would not affect the membrane potential of remaining intact mitochondria and provides
an explanation for the change in cytochrome c distribution in the absence of a loss of mito-
chondrial membrane potential. The ability of camptothecin to induce caspase 9 activity com-
bined with a change in mitochondrial membrane potential and a lack of large granule
formation with MDC confirms previous reports that camptothecin is able to cause cell death
via the intrinsic apoptotic pathway.
Autophagy, a pro-survival mechanism is not normally associated with apoptotic features
like nuclear fragmentation, caspase activation and annexin V binding to phosphatidyl-serine as
seen in this study. However, autophagic cell death is well described in the literature. Cyto-
plasmic vacuolisation is a prominent feature of paraptosis, which includes cytoplasmic vacuoli-
sation, mitochondrial swelling and endoplasmic reticulum stress and annexin V binding to
membranes. However, paraptosis is not associated with caspase activation, nuclear fragmenta-
tion and the presence of apoptotic bodies, thereby excluding the possibility of the nucleosides
causing cell death by discreet paraptosis [52, 53].
Novel Nucleosides Induce Unusual Apoptotic Response
PLOS ONE | DOI:10.1371/journal.pone.0138607 September 21, 2015 26 / 31
Nucleoside 5 effects on actin aggregation is of particular interest and require further investi-
gation. The formation of actin aggregates has implications for cell survival and completion of
mitosis [54]. This occurred selectively in HT-29 cells but not in the Caco-2 cells. This is an
early event and was typically seen within hours of addition of nucleoside 5 to the cells. It may
be of great importance that this occurs in conjunction with apoptosis and potential autophagic
cell death. The formation of actin aggregates, combined with its low IC50 values and ability to
induce apoptosis, identifies nucleoside 5 as a promising lead compound.
This study has shown that the nucleosides induced apoptosis in combination with extensive
cytoplasmic vacuole formation. This association, while not a common occurrence, has been
described previously [54, 55]. Preliminary investigations indicate that two of the nucleosides
are able to cause the formation of autophagosomes. A study on the effects of nucleoside 2 and 5
on autophagic flux will increase the understanding of the interplay between the two major
types of cell death, apoptosis and autophagy. Compounds that are able to cause cytoplasmic
vacuolisation in addition to inducing apoptosis and autophagic cell death may prove to have a
therapeutic advantage, especially since the apoptotic response is compromised in many types
of cancer and is associated with resistance as well as therapeutic failure.
Conclusions
The nucleoside analogue class of cancer drugs are important in the management of cancer and
viral infections. The current study showed a time and dose-dependent induction of apoptosis
with a series of novel, structurally related nucleoside analogues in both HT-29 and Caco-2
colon cancer cells. Three nucleosides were identified to be significantly cytotoxic (p< 0.05) to
the HT-29 and Caco-2 cell lines, and were able to induce apoptosis in the cells at micromolar
concentrations. Importantly, the nucleosides showed a degree of selective cytotoxicity towards
the cancer cell lines, with minimal cytotoxicity against normal unstimulated leukocytes. The
proteolytic phase of apoptosis was initiated after a two hour exposure period to these nucleo-
sides. The novel nucleoside analogues were also associated with an increase in cytoplasmic
cytochrome c levels, in the absence of a loss of mitochondrial membrane potential. Although
possibly mediated by autophagy, this phenomenon, the role of autophagy and autophagic flux
in cell death caused by these nucleosides do require further investigation. Additionally, all
three nucleosides induced the rapid formation of non-autophagic cytoplasmic vacuoles. Nucle-
oside 5 treatment resulted in changes in the cytoskeleton of HT-29 cells, causing the aggrega-
tion of actin, which may indicate its potential to disrupt the mitosis. The induction of
apoptosis is considered to be the main mechanism underlying the therapeutic efficacy of some
anticancer drugs. In view of the described cytoplasmic vacuolization, together with apoptosis
and potentially autophagy, the nucleoside analogues described here certainly warrant further
investigation.
Supporting Information
S1 Fig. Representative dose response curves of nucleoside 1, 2, 5 and camptothecin on HT-
29 and Caco-2 cells. Cells were exposed to a concentration range (0.005–120 μM) of nucleo-
sides and camptothecin for 48 hrs and cell viability was determined by the MTT assay.
(TIF)
S2 Fig. Representative scattergraphs showing the changes in the mitochondrial membrane
potential of HT-29 and Caco-2 cells. Cells were exposed to 100 μM of the nucleosides for 24
hours and stained with JC-1. Untreated HT-29 cells (A), HT-29 treated with camptothecin (B),
HT-29 cells treated with nucleoside 5 (C), Caco-2 cells treated with camptothecin (D) and
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nucleoside 2 (E).
(TIF)
S3 Fig. Representative scattergraphs showing typical apoptotic and necrotic HT-29 and
Caco-2 cell populations as detected by annexin V-FITC and propidium iodide staining.
Cells were exposed to 100 μM of the nucleosides for 24 hours and stained with annexin V and
propidium iodide. (A) Untreated HT-29 cells, (B) Untreated Caco-2 cells (C) Caco-2 cells and
camptothecin, (D) Caco-2 cells and nucleoside 5, (E) HT-29 cells and nucleoside 1, (F) HT-29
cells and nucleoside 5.
(TIF)
S4 Fig. Camptothecin induce caspase 9 activity in contrast with nucleoside 1, 2 and 5. Cells
were exposed to 50 μM of test nucleosides and 20 μM of campthecin for 24 hours.
(TIF)
S5 Fig. Expression of Bcl-2 in HT-29 cells exposed to the test nucleosides. Cells were
exposed to 50 μM test nucleosides for 8 hours.Scalebar: 20 μm.
(TIF)
S6 Fig. Expression of Bcl-2 in Caco-2 cells exposed to the test nucleosides. Cells were
exposed to 50 μM test nucleosides for 8 hours. Scalebar: 20 μm.
(TIF)
S7 Fig. Expression of Bax in HT-29 cells exposed to the test nucleosides. Cells were exposed
to 50 μM test nucleosides for 8 hours. Scalebar: 20 μm.
(TIF)
S8 Fig. Expression of Bax in Caco-2 cells exposed to the test nucleosides. Cells were exposed
to 50 μM test nucleosides for 8 hours. Scalebar: 20 μm.
(TIF)
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